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Abstract
The heart has emerged as an important organ in the regulation of systemic lipid homeosta-
sis; however, the underlying mechanism remains poorly understood. Here, we show that
Drosophila cardiomyocytes regulate systemic lipid metabolism by producing apolipopro-
tein B-containing lipoproteins (apoB-lipoproteins), essential lipid carriers that are so far
known to be generated only in the fat body. In a Drosophila genetic screen, we discov-
ered that when haplo-insufficient, microsomal triglyceride transfer protein (mtp), required
for the biosynthesis of apoB-lipoproteins, suppressed the development of diet-induced
obesity. Tissue-specific inhibition of Mtp revealed that whereas knockdown of mtp only in
the fat body decreases systemic triglyceride (TG) content on normal food diet (NFD) as
expected, knockdown of mtp only in the cardiomyocytes also equally decreases systemic
TG content on NFD, suggesting that the cardiomyocyte- and fat body-derived apoB-lipo-
proteins serve similarly important roles in regulating whole-body lipid metabolism. Unex-
pectedly, on high fat diet (HFD), knockdown of mtp in the cardiomyocytes, but not in fat
body, protects against the gain in systemic TG levels. We further showed that inhibition
of the Drosophila apoB homologue, apolipophorin or apoLpp, another gene essential for
apoB-lipoprotein biosynthesis, affects systemic TG levels similarly to that of Mtp inhibi-
tion in the cardiomyocytes on NFD or HFD. Finally, we determined that HFD differentially
alters Mtp and apoLpp expression in the cardiomyocytes versus the fat body, culminating
in higher Mtp and apoLpp levels in the cardiomyocytes than in fat body and possibly
underlying the predominant role of cardiomyocyte-derived apoB-lipoproteins in lipid met-
abolic regulation. Our findings reveal a novel and significant function of heart-mediated
apoB-lipoproteins in controlling lipid homeostasis.
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Author Summary
The heart is increasingly recognized to serve an important role in the regulation of whole-
body lipid homeostasis; however, the underlying mechanisms remained poorly under-
stood. Here, our study in Drosophila reveals that cardiomyocytes regulate systemic lipid
metabolism by producing apolipoprotein B-containing lipoproteins (apoB-lipoproteins),
essential lipid carriers that are so far known to be generated only in the fat body (insect
liver and adipose tissue). We found that apoB-lipoproteins generated by the Drosophila
cardiomyocytes serve an equally significant role as their fat body-derived counterparts in
maintaining systemic lipid homeostasis on normal food diet. Importantly, on high fat diet
(HFD), the cardiomyocyte-derived apoB-lipoproteins are the major determinants of
whole-body lipid metabolism, a role which could be attributed to the HFD-induced up-
regulation of apoB-lipoprotein biosynthesis genes in the cardiomyocytes and their down-
regulation in the fat body. Taken together, our results reveal that apoB-lipoproteins are
new players in mediating the heart control of lipid metabolism, and provide first evidence
supporting the notion that HFD-induced differential regulation of apoB-lipoprotein bio-
synthesis genes could alter the input of different tissue-derived apoB-lipoproteins in sys-
temic lipid metabolic control.
Introduction
Obesity, a condition caused by a mismatch between energy consumption and utilization, is a
significant risk factor for the development of Type II diabetes, hypertension and coronary
heart disease [1–3]. The aetiology of obesity is multifactorial, but it is widely accepted that die-
tary lipid is an important contributor [4]. Upon ingestion of a meal, dietary lipids (predomi-
nantly triglycerides (TGs), phospholipids, and cholesterol) are hydrolyzed in the intestinal
lumen and their products (free fatty acids, monoacylglycerols and free cholesterol) taken up by
the enterocytes. Enterocytes re-synthesize lipids in the endoplasmic reticulum (ER) and pack-
age them for secretion as chylomicrons (CMs) [5, 6]. The hepatocytes are the site where lipids
are packaged as the very low-density lipoproteins (VLDLs) and released into the circulation
[7]. The CMs and VLDLs are lipoprotein particles whose assembly in the enterocytes and
hepatocytes, respectively, require two major players: (a) apolipoprotein B (apoB), the structural
component of the lipoproteins, and (b) microsomal triglyceride transfer protein (Mtp), an ER-
resident protein that is thought to transfer lipids to apoB while the apoB transcript is being
translated, thus allowing apoB to fold correctly and assemble a primordial lipoprotein particle
[8–11]. Upon their maturation and secretion from the enterocytes and hepatocytes, the CMs
and VLDLs serve to transport lipids to the energy-requiring tissues (muscles) or to the energy-
storing adipose tissue, where the TGs in these apoB-containing lipoproteins (apoB-lipopro-
teins) are cleaved and the fatty acids taken up by the target tissues [12]. Mice that are deficient
in mtp, systemically or specifically in the liver or intestine, exhibit reduction in plasma triglyc-
eride and cholesterol levels (Chang, Liao et al., 1999, Iqbal, Parks et al., 2013, Raabe, Flynn
et al., 1998, Raabe, Veniant et al., 1999), supporting the idea that dysregulation of the mecha-
nisms that control lipid uptake and distribution could significantly perturb normal systemic
lipid homeostasis.
Drosophila is a well-established and genetically tractable model that shares many of the same
metabolic and energy-sensing pathways with vertebrates. Several models of HFD-induced obe-
sity have been developed in Drosophila which recapitulated the salient features of human obesity
and diabetes [13]. In Drosophila, Lipophorins (Lpp) are the major apoB-lipoproteins and are
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synthesized in the fat body, the principal fat depot and the functional equivalent of mammalian
liver and adipose tissue [14]. Like the CMs and VLDLs, Lpp are also essential elements in the
circulatory transport of neutral lipids and their generation in the fat body also requires Mtp and
the Drosophila apoB homologue, apolipophorin (apoLpp) [15]. Upon their release from the fat
body, Lpp can be recruited to the intestine, where they promote the absorption of dietary lipids
and mediate the transport of intestinal-derived lipids to other organs for storage or energy pro-
duction [15]. Flies in which Lpp are inhibited in the fat body have severely reduced levels of lip-
ids in their circulation [15], highlighting the important role of the apoB-lipoproteins derived
from the fat body in the maintenance of whole-body lipid metabolism.
The heart has been recognized in recent years to play an important role in the regulation of
systemic lipid metabolism [16–19]. For instance, studies in mice and Drosophila have revealed
that MED13, a subunit of the Mediator transcriptional complex, acts in the heart to control
whole-body lipid metabolism [17–19]. Despite increasing evidence supporting the heart as a
regulator of global lipid homeostasis, the underlying mechanisms remain poorly understood.
The genes for Mtp and apoB are expressed in the mouse cardiomyocytes [20], where they are
likely involved in the biosynthesis and secretion of apoB-lipoproteins from the heart [21, 22].
However, it is not clear whether apoB-lipoproteins derived from the heart could serve to influ-
ence systemic lipid homeostasis.
In this study using the Drosophila model, we reveal that the cardiomyocytes are a critical
source of apoB-lipoproteins that in turn serve an equally significant role as their fat body-
derived counterparts in the maintenance of systemic lipid homeostasis on normal food diet
(NFD). Importantly, on high fat diet (HFD), the cardiomyocyte-derived apoB-lipoproteins are
the predominant determinants of whole-body lipid metabolism. Our results further show that
HFD differentially alters relative Mtp and apoLpp gene expression in the fat body and cardio-
myocytes, culminating in their higher levels in the cardiomyocytes than in the fat body and
possibly underpinning the differential contribution of the cardiomyocyte- versus fat body-
derived apoB-lipoproteins on systemic lipid metabolic regulation under HFD conditions.
Results and Discussion
Genetic screening identifies Mtp as a key modulator of lipid metabolism
in response to a high-fat diet
To identify genes involved in the regulation of lipid metabolism, we performed a haplo-insuffi-
ciency screen for genes that could alter the pathogenesis of HFD-induced obesity in Drosophila
(S1A Fig). We first developed a feeding regimen in which control w1118 female and male flies
were reared on a NFD or a HFD (~48% of the calories derived from Crisco hydrogenated vege-
table oils) (S1B and S1B0 Fig) until adult eclosion. Measurement of whole-body triglyceride
(TG) levels in the newly eclosed adults revealed a significant increase (~1.5 fold) in TG levels
in HFD-reared compared to the NFD-reared progeny (S1C Fig). Consistent with that, Nile
Red staining of the fat body revealed that control w1118 HFD-fed larvae had increased neutral
lipid accumulation (S1D Fig, arrows) in the adipocytes (S1D Fig, outlines) compared to NFD-
fed larvae. Collectively, these data provide evidence that our HFD feeding regimen generates a
Drosophila model of diet-induced obesity.
Using the same feeding regimen to screen a collection of deficiency lines, we identified
three overlapping deficiency lines, Df(2L)ED1378,Df(2L)BSC333, and Df(2L)Exel7080within
chromosome 2L that displayed significant decreases in TG levels compared to control w1118
flies on HFD (Fig 1A and 1B). Moreover, the TG levels in these deficiency lines under NFD
conditions are comparable to those under HFD conditions (Fig 1B). Analysis of the deficiency
lines revealed that mtp is included in the gene deletions in all three deficiency lines (Fig 1A).
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Fig 1. Genetic screening identifies Mtp as a gene for determining systemic lipid metabolism. (A)
Schematic of the results of the genetic screen showing the location of the mtp gene (blue symbol) on
chromosome 2L. Red bars indicate deletions in the three deficiency lines investigated here: Df(2L)
ED1378, Df(2L)BSC333, and Df(2L)Exel7080. (B) Whole-body TG levels of newly eclosed control
(w1118) flies and deficiency lines on NFD or HFD. For each genotype, a 1:1 ratio of males:females was
analyzed. P-values are from Student’s t-test and are between control w1118 and deficiency lines within
NFD or HFD, or between NFD and HFD for the same genotype. (C) Whole-body TG levels of newly
eclosed control flies (Arm-Gal4), and flies with whole-body KD of mtp (Arm-Gal4>mtpRNAi) on NFD and
HFD. For each genotype, a 1:1 ratio of males:females was analyzed. P-values are from Student’s t-test
and are between Gal4 control and Gal4-mediated RNAi lines within NFD or HFD, or between NFD and
HFD for the same genotype. (D) Whole-body TG levels of newly eclosed control flies (Da-Gal4), and flies
with whole-body KD of mtp (Da-Gal4>mtpRNAi) on NFD and HFD. For each genotype, a 1:1 ratio of
males:females was analyzed. P-values are from Student’s t-test and are between Gal4 control and Gal4-
mediated RNAi lines within NFD or HFD, or between NFD and HFD for the same genotype. In (B), (C)
and (D), TG levels (μg/μl) were normalized to total protein (μg/μl). Results are expressed as the fold
change in whole fly normalized TG compared with that of the wild-type w1118 or Gal4 control flies on NFD
(set to 1.0). Results are the mean ± SEM of the indicated number of flies (N) analyzed over at least 5
independent experiments. (E) Colorimetric assay of food intake in control w1118 third instar larvae and
third instar larvae with Gal4 driver only (Arm-Gal4) or with whole body knockdown of mtp using Arm-Gal4
(Arm-Gal4>mtpRNAi). Results are the mean ± SEM of the indicated number of larvae (N) analyzed over 3
independent experiments. P-values are from Student’s t-test.
doi:10.1371/journal.pgen.1006555.g001
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As a role of Mtp in the control of lipid levels has previously been shown in Drosophila [15], we
tested whether inhibition of Mtp could cause a resistance in the HFD-induced gain in TG lev-
els, by performing RNA interference (RNAi)-mediated knockdown (KD) of mtp using the
ubiquitous Armadillo-Gal4 (Arm-Gal4) and Daughterless-Gal4 (Da-Gal4) drivers. We found
that newly-eclosed whole flies that ubiquitously expressed mtp RNAi (Arm-Gal4>mtpRNAi or
Da-Gal4>mtpRNAi) displayed significantly (Fig 1C) or near-significantly (Fig 1D) lower sys-
temic TG levels than Arm-Gal4 or Da-Gal4 control flies on HFD. Moreover, the Arm-
Gal4>mtpRNAi or Da-Gal4>mtpRNAi flies did not show any significant elevation in overall TG
levels on HFD compared to NFD (Fig 1C and 1D). Such suppression in the gain in systemic
TG content associated with Mtp inhibition was not due to changes in feeding behavior, as the
Arm-Gal4>mtpRNAi larvae had similar food consumption as the control w1118 or control Arm-
Gal4 larvae on NFD or HFD (Fig 1E). Taken together, these results support a role for Mtp in
the control of systemic lipid metabolism.
Inhibition of Mtp in fat body and cardiomyocytes affect normal systemic
triglyceride levels
Mtp was reported to function in the fat body to promote the generation of apoB-lipoproteins
from the fat body [15]. We therefore determined whether the fat body could be the major or
sole tissue that Mtp acts in to regulate whole-body lipid metabolism, by probing the tissue-spe-
cific contribution of Mtp via targeted RNAi-mediated mtp KD in different tissues followed by
analyses of whole-body TG levels on NFD. S1 Table provides a summary of the different Gal4
drivers used to induce mtp KD and their effects on developmental timing and viability. We
found that KD of mtp specifically in the fat body using three different fat body-specific Gal4
drivers (S2A and S2B Fig) led to a significant reduction in whole-body TG levels compared to
their respective controls under NFD condition (Fig 2A–2C; S3A Fig). However, strikingly,
when we KD mtp specifically in the cardiomyocytes using the myocardial-specific Hand- and
TinC-Gal4 drivers, we also found a significant lowering of whole-body TG levels in the newly-
eclosed adult flies relative to their respective controls under NFD condition (Fig 2D and 2E).
On the other hand, targeted KD of mtp in the nonmyocytic pericardial cells of the Drosophila
heart [23], using the Sticks-n-stones (Sns)-Gal4 driver [24], did not significantly affect systemic
TG levels in the newly-eclosed adult KD flies relative to control flies on NFD (S4A Fig). In
addition, we found that KD of mtp specifically in the central nervous system or intestine had
no effect on whole-body TG levels compared to the respective controls on NFD in the newly-
eclosed adult flies (S4B and S4C Fig). Taken together, these findings reveal a previously-unrec-
ognized role of Mtp in the cardiomyocytes in regulating whole-body lipid metabolism under
NFD conditions.
Cardiomyocyte Mtp is the main determinant of whole-body lipid
metabolism on high-fat diet
We next asked whether Mtp in the fat body and/or cardiomyocytes could serve similar roles in
the regulation of systemic lipid metabolism under HFD conditions. To test that, we performed
targeted KD of mtp in the fat body and assessed whole-body TG levels on HFD. We postulated
that if Mtp serves a similar function in the fat body on whole-body lipid metabolic regulation
on HFD as on NFD, then total TG levels would be lower in the mtp KD flies relative to control
flies under HFD condition. Unexpectedly, the KD of mtp in fat body led to an increase in total
TG content comparatively to control flies in response to high dietary fat intake (Fig 2A–2C;
S3A Fig), suggesting that while Mtp in the fat body critically regulates systemic lipid metabo-
lism on NFD, it does not influence lipid metabolic responses to HFD. In contrast, silencing of
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mtp specifically in the cardiomyocytes led to a significant decrease in whole-body TG levels rel-
ative to the control on HFD, as seen on NFD (Fig 2D and 2E). In whole larvae, whereas tar-
geted KD of mtp in the cardiomyocytes using Hand-Gal4 did not elicit any significant change
in systemic TG level compared to the control on HFD (S3B Fig), there was a trend of whole-
body TG content decrease in larvae in which mtp silencing in the cardiomyocyte was directed
using TinC-Gal4 (S3C Fig). We also targeted mtp KD specifically in the cardiomyocytes and
skeletal muscles using the muscle-specific Mhc-Gal4 driver and again found a significant
Fig 2. Fat body and cardiomyocyte Mtp regulate systemic lipid metabolism differently on normal food
diet and high fat diet. (A–C) Whole-body TG levels of newly-eclosed flies with Gal4 drivers only (controls) or
with fat body-specific knockdown of mtp using R4-Gal4 (A), ppl-Gal4 (B), or Lsp2-Gal4 (C) on NFD (blue) or HFD
(red). (D-E) Whole-body TG levels of newly-eclosed flies with Gal4 drivers only (controls) or with cardiomyocyte-
specific knockdown of mtp using Hand-Gal4 (D), or TinC-Gal4 (E) on NFD (blue) or HFD (red). (F) Whole-body
TG levels of newly-eclosed flies with Gal4 drivers only (controls) or with muscle-specific knockdown of mtp using
Mhc-Gal4 on NFD (blue) or HFD (red). In all cases, TG levels (μg/μl) were normalized to total protein (μg/μl).
Results are expressed as the fold change in whole fly normalized TG compared with that of the Gal4 control flies
on NFD (set to 1.0). Results are the mean ±SEM of the indicated number of flies (N) analyzed over at least 5
independent experiments. P-values are from Student’s t-test and are between Gal4 control and Gal4-mediated
RNAi lines within NFD or HFD, or between NFD and HFD for the same genotype.
doi:10.1371/journal.pgen.1006555.g002
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down-regulation of systemic TG levels in the Mhc-Gal4>mtpRNAi flies compared to the control
on HFD (Fig 2F). On the other hand, inhibition of Mtp in the pericardial cells, central nervous
system or intestine did not significantly alter whole-body TG levels relative to the controls on
HFD (S4A–S4C Fig). In sum, these results indicate that Mtp in the cardiomyocytes serves a
predominant role in the regulation of systemic lipid metabolism under HFD condition.
One possibility for the HFD-dominant effect of the cardiomyocytes on systemic lipid
metabolism could be due to HFD-induced cardiac dysfunction, which has been previously
reported in adult flies fed on a coconut oil HFD [25]. For instance, HFD-induced cardiac dys-
function could perturb hemolymph flow and elicit more extensive systemic effects on lipid
metabolism. To investigate this possibility, we examined the cardiac contractility of wandering
third-instar larvae that were fed, in our case, on NFD or HFD for about 4 days (after egg hatch-
ing) (S1A Fig). Although such short-term feeding on HFD only during the larval stage was suf-
ficient to induce significant lipid accumulation in the larval fat body (S1D Fig), it caused only
mild levels of lipid deposition in the heart compared to NFD-fed larvae (S5A Fig). Moreover,
there was no significant difference between NFD- and HFD-fed larvae in terms of heart period
(S5B and S5C Fig), heartbeat regularity (S4D Fig) and fractional shortening (S5E Fig), cardiac
contractility parameters that are likely important regulators of hemolymph flow. There were
also no significant differences in heart tube dimensions between the HFD- and NFD-fed larvae
during cardiac relaxation (S5F Fig) and contraction (S5G Fig). We conclude that the cardio-
myocytes modulate systemic lipid metabolism in a manner that is independent of cardiac per-
formance under HFD conditions.
It was previously shown that Mtp could play a role during Drosophila trachea development
[26]. This prompted us to examine whether Mtp could also regulate proper heart development
and function which in turn modulates systemic lipid metabolism. To test that, we targeted the
KD of mtp in cardiomyocytes using Hand-Gal4 and performed heart functional analyses on
the newly eclosed adult flies, a stage when lipid metabolic alterations were already apparent in
flies with mtp KD in the heart (Fig 2D–2F). We found that there were no significant differences
between the control and Hand-Gal4>mtpRNAi flies in their heart period (S6A Fig), heart
rhythm (S6B Fig), heart tube dimensions during cardiac relaxation (S6C Fig) and contraction
(S6D Fig), or fractional shortening (S6E Fig) on NFD or HFD. As the inhibition of Mtp in the
cardiomyocytes had no obvious effects on any major aspects of heart function on under either
diet condition, our results suggest that Mtp in the cardiomyocytes regulates systemic lipid
metabolism in a manner that is independent of any potential influence of Mtp on cardiac per-
formance maintenance.
Lipophorins mediate the effects of Mtp in fat body and cardiomyocytes
on systemic lipid metabolism
Mtp is an essential factor in the assembly and secretion of the major apoB-lipoproteins termed
lipophorins or Lpp in flies [15, 27]. If Mtp exerts its effect on systemic lipid metabolism via
Lpp, we would expect that inhibition of apoLpp (protein scaffold of Lpp and another essential
factor in Lpp biosynthesis) would recapitulate the systemic lipid metabolic effects associated
with the silencing of mtp. Indeed, as shown in Fig 3A, the fat body-targeted KD of apoLpp led
to a significant lowering of whole-body TG levels on NFD but not on HFD relative to the con-
trol, metabolic effects that recapitulated those seen in the fat body-specific mtp KD flies under
NFD and HFD conditions (Fig 2A–2C). Next, we performed the KD of apoLpp only in the car-
diomyocytes using Hand-Gal4 (S2C Fig) and TinC-Gal4 drivers and found that that resulted in
significantly lower levels of systemic TG levels compared to the controls on NFD or HFD (Fig
3B and 3C; S3B and S3C Fig), metabolic effects that are reminiscent of those associated with
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mtp silencing in the cardiomyocytes under the different diet conditions (Fig 2D–2F). We fur-
ther investigated the epistatic relationship between Mtp and apoLpp on systemic lipid meta-
bolic control in the cardiomyocytes. We first generated a UAS-mtp+ fly line which when
crossed to flies bearing the Arm-Gal4 driver resulted in an approximate two-fold increase in
wild-type mtp expression throughout the body (Fig 3D). We then crossed UAS-mtp+ flies to
Fig 3. Fat body and cardiomyocyte apoLpp regulate systemic lipid metabolism differently on normal
food diet and high fat diet. (A) Whole-body TG levels of newly-eclosed flies with Gal4 driver only (control) or
with fat body-specific knockdown of apoLpp using ppl-Gal4 (A) on NFD (blue) or HFD (red). (B, C) Whole-body
TG levels of newly-eclosed flies with Gal4 drivers only (controls) or with cardiomyocyte-specific knockdown of
apoLpp using Hand-Gal4 (B), or TinC-Gal4 (C) on NFD (blue) or HFD (red). (D) RT-PCR analysis of mtp mRNA
levels in whole flies with Arm-Gal4 driver only (control) or with Arm-Gal4-induced overexpression of full-length
mtp (mtp+). Actin serves as an internal control. (E) Whole-body TG levels of newly-eclosed flies with Gal4 driver
only (control), with cardiomyocyte-specific overexpression of mtp+ using TinC-Gal4, or with cardiomyocyte-
specific overexpression of mtp+ and apoLppRNAi using TinC-Gal4 on NFD (blue) or HFD (red). In A-C and E,
TG levels (μg/μl) were normalized to total protein (μg/μl). Results are expressed as the fold change in whole fly
normalized TG compared with that of the Gal4 control flies on NFD (set to 1.0). Results are the mean ±SEM of
the indicated number of flies (N) analyzed over at least 5 independent experiments. P-values are from Student’s
t-test and are between Gal4 control and Gal4-mediated RNAi lines within NFD or HFD, or between NFD and
HFD for the same genotype.
doi:10.1371/journal.pgen.1006555.g003
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flies harboring the cardiomyocyte-specific TinC-Gal4 driver, and found that the progenies
(TinC-Gal4>mtp+) displayed significant elevation in their TG levels compared to the control
on NFD or HFD (Fig 3E). Notably, these effects were alleviated by the concurrent inhibition of
apoLpp in the cardiomyocytes (TinC-Gal4>mtp+,apoLppRNAi) (Fig 3E). We conclude that
Mtp- and apoLpp-dependent generation of Lpp in the fat body and cardiomyocytes serves to
critically regulate systemic lipid metabolism under NFD and HFD conditions.
Cardiomyocyte-derived lipophorins control dietary lipid uptake from the
enterocytes and fat mobilization in the fat body
Next, we asked how the cardiomyocytes could modulate lipid metabolism in a systemic man-
ner. A previous study found that inhibition of Mtp or apoLpp in the fat body caused lipid accu-
mulation in the intestine on NFD, suggesting that Lpp could be recruited to the intestine from
the fat body for the uptake of dietary lipids into the circulation [15]. We found that KD of mtp
or apoLpp specifically in the fat body, using the ppl-Gal4 driver, increased the number of neu-
tral lipid droplets in the larval intestines compared to control intestines on NFD (Fig 4A–4C’;
see arrows in Fig 4B’ and 4C’), consistent with the previous study [15]. However, under HFD
condition, there was no significant difference in the levels of neutral lipids in the larval intes-
tine between the mtp KD and control flies (Fig 4D and 4E’), or between the apoLpp KD and
control flies (Fig 4D and 4D’ and 4F and 4F’), corroborating the notion that Lpp from the fat
body do not impact systemic lipid metabolism under HFD condition (Fig 2A and 2B and Fig
3A).
We next sought to determine the mechanism by which cardiomyocyte-derived Lpp regulate
systemic lipid metabolism. We found that under NFD conditions, targeted inhibition of Mtp
or apoLpp in the cardiomyocytes using the Hand-Gal4 driver (Fig 4G–4I’) also led to an
increase in larval intestinal lipid accumulation compared to control intestines (see arrows in
Fig 4H’ and 4I’), thereby supporting a similarly important role of the cardiomyocyte- and fat
body-derived Lpp in the regulation of systemic lipid metabolism via mediating the uptake of
dietary lipids from the intestine. On HFD however, whereas the inhibition of Mtp or apoLpp
specifically in the fat body did not significantly affect intestinal lipid levels compared to control
intestines (Fig 4D–4F’), the cardiomyocyte-specific mtp or apoLpp KD larvae still exhibited an
increase in intestinal lipid content relative to control intestines (Fig 4J–4L’; see arrows in Fig
4K’ and 4L’). Such accumulation of lipids in the intestines in the cardiomyocyte-specific mtp
or apoLpp KD larvae under HFD conditions was associated with a reduction in intestinal Lpp
abundance, as indicated by their decreased intestinal apoLpp staining relative to control intes-
tines (S7A–S7C Fig). These results thereby provide evidence that on HFD, the cardiomyocyte-
derived Lpp serve as major determinants of systemic lipid metabolism via their recruitment to
the intestine to promote the circulatory absorption of dietary lipids.
High-fat diet alters relative Mtp levels in the cardiomyocytes and fat body
To understand the HFD-associated predominant role of cardiomyocyte-derived Lpp mecha-
nistically, we investigated the expression levels of Mtp and apoLpp under NFD and HFD con-
ditions. We hypothesized that Mtp and/or apoLpp gene expression differentially changes in
the cardiomyocytes and fat body such that their expression levels are significantly higher in the
cardiomyocytes than in fat body in response to abundant dietary fat intake. Therefore, the KD
of mtp or apoLpp in the cardiomyocytes and not the fat body will have an obvious effect on sys-
temic lipid metabolism under HFD condition. To test this idea, we first analyzed Mtp mRNA
expression in the cardiomyocytes and fat body on NFD or HFD using quantitative RT-PCR.
First of all, we found that upon initiation of HFD feeding after egg hatching (S1A Fig), changes
Heart ApoB-Lipoproteins Control Systemic Lipid Metabolism
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in the relative expression of Mtp could be detected as early as in the wandering third instar lar-
val stage, about 4 days later (Fig 5). Strikingly, relative to NFD, HFD robustly down-regulated
Mtp transcript level by 16.7-fold in the larval fat body (Fig 5A) but strongly up-regulated Mtp
transcript level by 1.57-fold in the larval cardiomyocytes (Fig 5B). Inter-tissue comparison fur-
ther revealed that there was a significant 7.6-fold higher Mtp transcript level in the cardiomyo-
cytes than in fat body under HFD condition (Fig 5C), although normal transcript level of Mtp
was lower in the cardiomyocytes relative to the fat body (Fig 5D). We further determined
whether the changes in the Mtp gene expression in the fat body versus cardiomyocytes under
NFD and HFD conditions would also occur at the protein level. Indeed, Mtp protein content
in the larval fat body decreased under HFD condition relative to NFD condition (S8A Fig),
consistent with the change at mRNA level (Fig 5A). We next compared NFD and HFD Mtp
Fig 4. Inhibition of Mtp or apoLpp in fat body or cardiomyocytes promotes intestinal lipid accumulation
on normal food diet and high fat diet. (A-C’) Representative confocal images of Nile Red-stained lipid droplets
in the unfixed intestines of third instar larvae on NFD. (A, A’), control larvae (ppl-Gal4); (B, B’), larvae with fat
body-specific KD of mtp (ppl-Gal4>mtpRNAi); and (C, C’), larvae with fat body-specific KD of apoLpp (ppl-
Gal4>apoLppRNAi). (A, B, C) Lower magnification (10X) images with scale bars representing 100 μm. (A’, B’, C’)
Insets represent the magnified (20X) portion of the intestines (yellow boxes) with scale bar representing 70 μm.
Arrows in insets indicate lipid droplets within the enterocytes. (D-F’) Representative confocal images of Nile Red-
stained lipid droplets in the unfixed intestines of third instar larvae on HFD. (D, D’), control larvae (ppl-Gal4); (E,
E’), larvae with fat body-specific KD of mtp (ppl-Gal4>mtpRNAi); and (F, F’), larvae with fat body-specific KD of
apoLpp (ppl-Gal4>apoLppRNAi). (D, E, F) Lower magnification (10X) images with scale bars representing
100 μm. (D’, E’, F’) Insets represent the magnified (20X) portion of the intestines (yellow boxes) with scale bar
representing 70 μm. Arrows in insets indicate lipid droplets within the enterocytes. (G-I’) Representative confocal
images of Nile Red-stained lipid droplets in the unfixed intestines of third instar larvae on NFD. (G, G’), control
larvae (Hand-Gal4); (H, H’), larvae with cardiomyocyte-specific KD of mtp (Hand-Gal4>mtpRNAi); and (I, I’), larvae
with cardiomyocyte-specific KD of apoLpp (Hand-Gal4>apoLppRNAi). (G, H, I) Lower magnification (10X) images
with scale bars representing 100 μm. (G’, H’, I’) Insets represent the magnified (20X) portion of the intestines
(yellow boxes) with scale bar representing 70 μm. Arrows in insets indicate lipid droplets within the enterocytes.
(J-L’) Representative confocal images of Nile Red-stained lipid droplets in the unfixed intestines of third instar
larvae on HFD. (J, J’), control larvae (Hand-Gal4); (K, K’), larvae with cardiomyocyte-specific KD of mtp (Hand-
Gal4>mtpRNAi); and (L, L’), larvae with cardiomyocyte-specific KD of apoLpp (Hand-Gal4>apoLppRNAi). (J, K, L)
Lower magnification (10X) images with scale bars representing 100 μm. (J’, K’, L’) Insets represent the magnified
(20X) portion of the intestines (yellow boxes) with scale bar representing 70 μm. Arrows in insets indicate lipid
droplets within the enterocytes.
doi:10.1371/journal.pgen.1006555.g004
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Fig 5. High fat diet alters relative Mtp expression levels in the cardiomyocytes and fat body. (A, B) Relative mRNA
levels of Mtp in larval fat body (A) and larval hearts (B) on NFD and HFD. Results are expressed as the fold difference
compared with the NFD condition. Values were normalized with gapdh. ***p < 0.001, by two-tailed paired t-test analyzed
over 3 independent experiments. (C) Relative mRNA levels of Mtp in in larval heart relative to larval fat body on HFD.
Results are expressed as the fold difference. Values were normalized with gapdh. *p < 0.05, ***p < 0.001, by two-tailed
paired t-test analyzed over 3 independent experiments. (D) Relative mRNA levels of Mtp in larval heart relative to larval fat
body on NFD. Results are expressed as the fold difference. Values were normalized with gapdh. *p < 0.05, ***p < 0.001,
by two-tailed paired t-test analyzed over 3 independent experiments. (E-E”) Representative confocal images of Mtp (E),
Boca (E’), and Mtp and Boca (E”) stainings of the hearts in the Hand-Gal4 control third instar larvae on NFD. Scale bars
represent 40 μm. Insets in E-E” represent the same portion of the heart tube (yellow boxes). Arrows in inset E mark Mtp and
Heart ApoB-Lipoproteins Control Systemic Lipid Metabolism
PLOS Genetics | DOI:10.1371/journal.pgen.1006555 January 17, 2017 11 / 25
levels in the larval cardiomyocytes by direct visualization of these proteins using immunofluo-
rescence. We observed that Mtp was weakly expressed in the cardiomyocytes on NFD (Fig 5E,
arrows in inset) but its expression was increased in response to HFD (Fig 5F, arrows in inset),
in line with the gene expression changes (Fig 5B). Cardiac-specific knockdown of mtp reduced
the immunofluorescence of Mtp in the cardiomyocytes on HFD (Fig 5G, arrows in inset),
indicative of the staining specificity of the Mtp antibody. We further found that on HFD, Mtp
partially localized with Boca, an endoplasmic reticulum (ER) marker [28], in the cardiomyo-
cytes (Fig 5F–5F”, compare arrows in insets 5F and 5F’), thus establishing that Mtp in the Dro-
sophila cardiomyocytes resides, in part, in the ER.
High-fat diet alters relative apoLpp levels in the cardiomyocytes and fat
body
Next, we examined whether HFD also differentially alters apoLpp expression in the cardio-
myocytes versus the fat body, as seen for Mtp (Fig 5). Our results showed that apoLpp tran-
script level was decreased on HFD compared to NFD in the larval fat body, by about 3.75 fold
(Fig 6A). In contrast, relative to NFD, HFD dramatically increased apoLpp mRNA level by
23.5 fold in the cardiomyocytes (Fig 6B), to a much greater extent than Mtp transcript level
activation in the same tissue (Fig 5B). Inter-tissue comparison revealed a significant 1.6-fold
increase in apoLpp transcript level in the cardiomyocytes compared to the fat body under
HFD condition (Fig 6C), even though NFD apoLpp transcript level was lower in the cardio-
myocytes than in fat body (Fig 6D). At the protein level, we found that apoLpp concentration
in the fat body was reduced in response to high dietary fat feeding (S8B Fig), in agreement
with the alteration in mRNA level (Fig 6A). Our examination of apoLpp directly in the cardio-
myocytes also revealed a higher expression level of apoLpp on HFD than on NFD, as shown by
the stronger punctate staining of apoLpp on HFD (Fig 6F, white arrows) relative to NFD (Fig
6E). Cardiac-specific knockdown of apoLpp abolished the punctate staining of apoLpp in the
cardiomyocytes on HFD (S2C Fig), indicative of the staining specificity of the apoLpp anti-
body. Unlike Mtp, minimal co-localization of apoLpp and Boca was detected in the cardio-
myocytes (Fig 6F”, arrows), suggesting that apoLpp was dynamically distributed throughout
the cell likely due to its association with lipoproteins. In all, our Mtp and apoLpp expression
data support our above hypothesis that HFD exerts an opposing effect on relative Mtp and
apoLpp levels in the cardiomyocytes and fat body that could contribute to the predominant
role of cardiomyocyte-derived Lpp in determining systemic lipid metabolic responses to HFD.
Cardiomyocyte-derived Lpp constitute a significant portion of total Lpp
pool in the circulation under high-fat diet condition
One possible outcome of the above-seen HFD-induced differential expression of Mtp and
apoLpp expression in the fat body versus the cardiomyocytes could be a decreased and
DAPI nuclear staining in three cardiomyocytes whereas arrows in inset E’ and inset E” mark Boca and DAPI staining and
Mtp and Boca staining in the same three cardiomyocytes, respectively. (F-F”) Representative confocal images of Mtp (F),
Boca (F’), and Mtp and Boca (F”) stainings of the hearts in the Hand-Gal4 control third instar larvae on HFD. Scale bars
represent 40 μm. Insets in F-F” represent the same portion of the heart tube (yellow boxes). Arrows in inset F mark Mtp and
DAPI nuclear staining in four cardiomyocytes whereas arrows in inset F’ and inset F” mark Boca and DAPI staining and Mtp
and Boca staining in the same four cardiomyocytes, respectively. (G-G”) Representative confocal images of Mtp (G), Boca
(G’), and Mtp and Boca (G”) stainings of the hearts in the Hand-Gal4−mediated mtp KD third instar larvae on HFD. Scale
bars represent 40 μm. Insets in G-G” represent the same portion of the heart tube (yellow boxes). Arrows in inset C mark
Mtp and DAPI nuclear staining in two cardiomyocytes whereas arrows in inset G’ and inset G” mark Boca and DAPI
staining and Mtp and Boca staining in the same two cardiomyocytes, respectively.
doi:10.1371/journal.pgen.1006555.g005
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Fig 6. High fat diet alters relative apoLpp expression levels in the cardiomyocytes and fat body. (A, B) Relative
mRNA levels of apoLpp in larval fat body (A) and larval hearts (B) on NFD and HFD. Results are expressed as the fold
difference compared with the NFD condition. Values were normalized with gapdh. ***p < 0.001, by two-tailed paired t-test
analyzed over 3 independent experiments. (C) Relative mRNA levels of apoLpp in in larval heart relative to larval fat body
on HFD. Results are expressed as the fold difference. Values were normalized with gapdh. *p < 0.05, ***p < 0.001, by
two-tailed paired t-test analyzed over 3 independent experiments. (D) Relative mRNA levels of apoLpp in larval heart
relative to larval fat body on NFD. Results are expressed as the fold difference. Values were normalized with gapdh.
*p < 0.05, ***p < 0.001, by two-tailed paired t-test analyzed over 3 independent experiments. (E-E”) Representative
confocal images of apoLpp (E), Boca (E’), and apoLpp, Boca and DAPI (E”) in cardiomyocytes of the Hand-Gal4 control
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increased production of Lpp from the fat body and cardiomyocytes, respectively. In that case,
we reasoned that inhibition of the Lpp biosynthesis genes only in the cardiomyocytes on HFD
would significantly impact total Lpp abundance in the circulation, whereas disruption of those
genes only in the fat body on HFD should have a minimal impact. To test this, we determined
the total amount of circulating Lpp via western blot analysis of apoLpp (protein scaffold of
Lpp) upon the silencing of mtp specifically in the fat body (using ppl-Gal4) or in the cardio-
myocytes (using Hand-Gal4) in third-instar larvae on NFD and HFD. As shown in S9 Fig,
inhibition of Mtp only in the fat body led to a detectable reduction in hemolymph Lpp level
compared to the control on NFD (S9A Fig) but not on HFD (S9B Fig). Conversely, targeted
disruption of mtp in the cardiomyocytes significantly attenuated the hemolymph concentra-
tion of Lpp compared to the control on HFD (S9D Fig) while eliciting a modest effect on NFD
(S9C Fig). We further argue that the diminished level of hemolymph Lpp upon KD of mtp in
the cardiomyocytes on HFD is a corollary of the reduced ability of the mtp-silenced cardio-
myocytes to secrete Lpp, as Mtp is essential for the cellular release of Lpp [15, 27]. If so, more
Lpp should be retained in the mtp-silenced cardiomyocytes compared to control cardiomyo-
cytes on HFD. In agreement with this, we observed strong accumulation of apoLpp in the
mtp-silenced cardiomyocytes relative to control cardiomyocytes in response to high dietary fat
(compare Fig 6F and 6G, arrows), which correlates with the reduced hemolymph level of Lpp
in the cardiomyocyte-specific mtp KD larvae over control larvae on HFD (S9D Fig). These
results corroborate our genetic data in supporting a particularly crucial function of Mtp in the
cardiomyocytes in promoting the cardiac release of Lpp into the circulation during HFD con-
dition, demonstrating that cardiomyocyte Mtp serves as the predominant determinant of
HFD-induced systemic lipid metabolic responses.
Several factors have recently been identified to act in the heart to control systemic lipid
homeostasis, such as the atrial natriuretic peptide/brain natriuretic peptide and the Mediator
component Med13 [16, 17]. These findings define the heart as an important organ in regulat-
ing whole-body lipid metabolism and are beginning to unravel the mechanisms by which the
heart regulates systemic lipid homeostasis. Our study now uncovers that in Drosophila, the car-
diomyocytes are a critical source of apoB-lipoproteins that in turn serve an equally significant
role as their fat body-derived counterparts in the maintenance of systemic lipid homeostasis
on NFD (Fig 7A). Importantly, under HFD conditions, the cardiomyocyte-derived apoB-lipo-
proteins are the predominant determinants of whole-body lipid metabolism (Fig 7B). These
findings provide new insight into the mechanisms that mediate the heart control of systemic
lipid metabolism, and it remains to be determined whether the different cardiac-derived fac-
tors could act in concert to regulate global lipid metabolism; for instance, whether Med13
could influence Mtp or apoLpp expression in the heart under different diet conditions.
In consideration of the understanding that TG levels are very dependent on genetic back-
ground, in this study, we analyzed the TG/protein ratio between each driver Gal4 control flies
and the same Gal4>UAS-RNAi knockdown flies that are progenies derived from a single
third instar larvae on NFD. Scale bars represent 40 μm. Boca marks the endoplasmic reticulum and DAPI marks the
nucleus in each cardiomyocyte. (F-F”) Representative confocal images of apoLpp (F), Boca (F’), and apoLpp, Boca and
DAPI (F”) in cardiomyocytes of the Hand-Gal4 control third instar larvae on HFD. White arrows in F and F” indicate the
apoLpp puncta which reflect the presence of Lpp. Yellow arrows in F’ and F” indicate the endoplasmic reticulum marker
Boca, and DAPI marks the nuclei in the cardiomyocytes. The magenta arrow in F” indicates the co-localization of apoLpp
and Boca. Scale bars represent 40 μm. (G-G”) Representative confocal images of apoLpp (G), Boca (G’), and apoLpp,
Boca and DAPI (G”) in cardiomyocytes of the Hand-Gal4-mediated mtp KD third instar larvae on HFD. White arrows in G
and G” indicate the strong punctate staining of apoLpp which reflects the accumulation of Lpp. Yellow arrows in G’ and G”
indicate the endoplasmic reticulum marker Boca, and DAPI marks the nuclei in the cardiomyocytes. Scale bars represent
40 μm.
doi:10.1371/journal.pgen.1006555.g006
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cross. We clearly observed an alteration in normalized TG levels when comparing between the
fat body- or cardiomyocyte-specific Gal4 control and Gal4>UAS-RNAi knockdown from
within the same cross on NFD. Importantly, on HFD, we still observed differential effects on
normalized TG levels in the cardiomyocyte-specific, but not in fat body-specific Gal4-medi-
ated knockdown, compared to their respective Gal4 control. These results are not confounded
by genetic backgrounds as the genotypes are identical regardless of normal fat or high fat diets.
In addition, we used more than one Gal4 driver to generate each tissue-specific knockdown so
as to avoid any Gal4-specific genetic background effects.
Interestingly, our results showed that mtp silencing in the fat body or in cardiomyocytes
(Fig 2) induces similar reduction in normalized TG content as that of ubiquitous mtp silencing
(Fig 1C and 1D). Several scenarios could explain this phenomenon. One possibility is that the
ubiquitous knockdown of mtp only partially decreases mtp expression in both the fat body and
cardiomyocytes, whereas knocking down mtp expression using either fat body or cardiomyo-
cyte-specific Gal4 drivers nearly-abolishes Mtp levels in either tissue. Hence, the addictive
effects on normalized TG reduction of partially knocking down mtp expression in both the fat
body and cardiomyocytes mediated by the ubiquitous Gal4 drivers could be similar to the sole
effect of a complete (or near complete) loss of Mtp in either the fat body or cardiomyocytes.
On the other hand, it is also possible that the Lpp derived from the cardiomyocytes and from
fat body could be further modified so that each population plays an important but distinct role
in the regulation of systemic TG levels. It is also possible that fat body and cardiomyocytes
could contribute to Lpp production in a differentially circadian fashion—they generate Lpp at
different times of day. Each of the above scenarios does not require the contributions of the
cardiomyocytes and fat body to be additive.
Fig 7. A model depicting the relative contributions of Lpp derived from the fat body and
cardiomyocytes in controlling systemic lipid metabolism on NFD and HFD. (A) On NFD, Lpp derived
from the cardiomyocytes play an equally important role as Lpp derived from the fat body in systemic lipid
homeostasis maintenance. Higher levels of Mtp and apoLpp (blue threads) are present in the fat body than in
cardiomyocytes on NFD. Both the cardiomyocyte- and fat body-derived Lpp are recruited to the intestine
where they promote the uptake of dietary lipids from the enterocytes and transport the dietary lipids to
peripheral tissues for energy production or for storage in the fat body. (B) HFD induces an upregulation of the
relative expression of Mtp and apoLpp in the cardiomyocytes (red arrows) and downregulation of their relative
expression in the fat body (green arrows), culminating in higher levels of Mtp (bold) and apoLpp (blue threads)
in the cardiomyocytes than in the fat body. This could underlie the predominant role of the cardiomyocyte-
derived Lpp in the determining of lipid metabolic responses to HFD (thick versus broken arrows, B).
doi:10.1371/journal.pgen.1006555.g007
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Excessive dietary fat consumption has been shown to differentially alter the relative levels of
Mtp or apoB in different tissues such as the liver and intestine in various mammalian models
[29–35]. However, whether such differential changes in Mtp and apoLpp expression in differ-
ent tissues in response to HFD could affect overall lipid metabolism is not known. Here, we
reveal that in Drosophila, high dietary fat also affects Mtp and apoLpp expression differently in
different tissues, with HFD dramatically increasing relative Mtp and apoLpp expression levels
in the cardiomyocytes and strongly diminishing relative Mtp and apoLpp levels in the fat
body, thus culminating in significantly higher levels of Mtp and apoLpp in the cardiomyocytes
than in the fat body (Fig 7B). One functional consequence of such, as suggested by our results,
could be to modulate the relative input of the apoB-lipoproteins derived from different tissues
on systemic lipid homeostasis regulation (Fig 7B). It remains to be determined how HFD
could differentially alter Mtp or apoLpp gene expression in the cardiomyocytes versus the fat
body, and how the subsequent alteration of apoB-lipoprotein production from the cardiomyo-
cytes versus fat body could impact the pathogenesis of obesity.
In conclusion, our results reveal a novel and significant function of the heart-mediated
apoB-lipoproteins in the control of systemic lipid metabolism in Drosophila. Given the conser-
vation of apoB-lipoprotein−mediated lipid transport pathways [36], these findings could pro-
vide new insights into mammalian apoB-lipoprotein physiology and regulation.
Materials and Methods
Fly stocks
The following strains were obtained from the Bloomington Stock Center: w1118 (BL6326),
UAS-mtpRNAi (VDRC15775), UAS-apoLppRNAi (BL33388), Da-Gal4 (BL5460), Arm-Gal4
(BL1560), Elav-Gal4 (BL458), cad-Gal4 (BL3042), R4-Gal4 (BL33832), Lsp2-Gal4 (BL6357),
ppl-Gal4 (BL58768), Mhc-Gal4 (BL38464), UAS-mCD8-GFP (BL5137), and the Bloomington
deficiency kit for chromosome 2L (DK2L). DK2L contains 102 stocks with molecularly defined
genomic deletions generated primarily by two groups, Exelixis and DrosDel [37]. The deficien-
cies were generated using FLP recombinase mediated excision of genomic DNA flanked by
two neighboring in trans P-elements (i.e. Piggybac and P(RS3)/P(XP) P-elements) [38–41].
The three deficiency lines further characterized in this study are Df(2L)ED1378 (BL9682), Df
(2L)BSC333 (BL 24357) and Df(2L)Exel7080 (BL7853). UAS-mtpRNAi was obtained from the
Vienna Drosophila Resource Center (15775). Other stocks used in this study were as follows:
Sns-Gal4 (a gift of Susan Abmayr, Stowers Institute, Kansas City); Hand-Gal4 (a gift of Lauren
Perrin, TAGC, France); TinCΔ4-Gal4 (abbreviated here to TinC-Gal4) (a gift of Rolf Bodmer,
Sanford-Burnham-Presby Medical Discovery Institute, La Jolla). The mtp cDNA was obtained
from Berkeley Drosophila Genome Project-Drosophila Genome Collection (BDGP-DGC)
clone containing full-length mtp (mtp+) cDNA (SD 01501). BDGP-DGC mtp clone was cloned
into pUAST vector. UAS-mtp+ transgenic flies were generated by Rainbow Transgenics.
Feeding regimen and genetic screening
Parental flies include control w1118 flies, flies from each of the 102 stocks from the 2L Defi-
ciency kit (DK2L), or for Gal4/UAS crosses, flies harboring the appropriate Gal4 driver with
flies harboring UAS-transgeneRNAi. Parental male and female flies (n = 35–40) were acclima-
tized on NFD for 1–2 days before being transferred to a fresh NFD vial or a fresh vial contain-
ing HFD food. Parents were maintained in their respective food vials until a single uniform
layer of eggs was deposited on the surface of food (typically in ~2 days for both NFD- and
HFD-fed flies). Parental flies were then removed and the progenies continued to be reared on
the same NFD or HFD vial. Progenies were collected at two different developmental
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windows–third instar larval and newly eclosed adult stages − for various analyses. Foraging
third instar larvae were collected for blue food feeding assays (see below). Wandering third
instar larvae were collected for the Nile Red staining of neutral lipid, for Western blot or
immunofluorescence analysis of Mtp and apoLpp levels in the fat body, heart, or intestine, and
for heart function analyses. Newly-eclosed male and female adults (equal ratio) were collected
for the measurement of whole-body TG levels and analyses of whole-body phospho-Akt levels.
Feeding assay
Foraging (feeding) third instar larvae were selected as described previously [42]. Briefly, paren-
tal flies as described above were allowed to lay eggs overnight in fly cages containing plates (100
mm x 15 mm, Fisher Scientific) with NFD. The following day, following a 2 hour pre-collection,
a 1 hour-egg collection was performed. At 21 hr after egg laying, all hatched larvae were
removed from the collection plate under a dissection microscope and the remaining eggs fur-
ther incubated for 3 hrs (corresponding to 0–3 hr after hatching (AH)). Approximately 30–40
newly hatched larvae were collected and transferred to a fresh NFD plate and allowed to grow
until 65–75 hr AH (early and late foraging third instar larvae) before being transferred to NFD
or HFD blue food, which was prepared in the same manner as NFD and HFD, except for the
addition of 1% (v/v) bromophenol blue (FD&C Blue Dye no. 1; Durkee). Larvae were allowed
to feed on the respective blue diets for 1 hour at room temperature, washed 3x in PBS, placed in
1.5 ml tubes and immediately frozen in liquid nitrogen and stored in -80˚C. Larvae (n = 5) were
subsequently homogenized in 100 μl ice-cold PBS containing 0.05% Triton X-100 (Sigma).
Homogenates were centrifuged at 13,000 rpm for 20 min and the supernatants were removed
and re-centrifuged at 13,000 rpm for 5 min. The supernatants were transferred to a 96-well
plate and the absorbance measured at 630 nm (SpectraMax Plus 384, Molecular Devices, CA).
Triglyceride assay
Triglyceride assay was performed as previously described [43]. Flies (10–15 per genotype) or
third-instar larvae (10–15 per genotype) were weighed and homogenized in PBS containing
0.1% Triton-X100 in an amount (μl) that is 8 X the total weight of flies (μg). The homogenates
were centrifuged and the supernatants were removed and incubated with Infinity Triglyceride
Reagent (Thermo Electron) for 30 min at 37˚C. The absorbance at 540 nm was then measured
and TG content was calculated from a standard curve constructed with solutions of known TG
concentrations (Thermo Electron). The results were normalized to the protein concentration
(μg/μl) of each sample (Bradford assay).
Nile red lipid staining
The fat bodies, intestines or hearts were dissected from wandering third instar larvae in 5 μg/
ml of Nile Red solution and then mounted. Slides were examined with a laser confocal micro-
scope (Leica DMRB) at 40X magnification.
Western blot analysis
Ten newly eclosed flies per genotype (for phospho-Akt), or fat bodies from twelve wandering
third instar larvae per genotype, or heart tubes from seventy wandering third instar larvae per
genotype were collected and homogenized in PBS containing 0.1% Triton-X100 and phospha-
tase and protease inhibitors (Sigma). Samples of 30~40 μg protein were resolved by SDS-PAGE
using Novex NuPAGE 10% Bis-Tris Gels (Invitrogen). For western blot analyses of circulating
Lpp, hemolymph extraction was performed as described in [44]. Basically, third-instar larvae
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were thoroughly washed and dried, then placed on a piece of parafilm and pierced with fine
forceps. Hemolymph was collected using fine capillary glass micropipettes and diluted 10-fold
on ice with phosphate-buffered saline. Protein quantification was performed on the diluted
samples and as precisely as possible, twenty-three μg protein per sample were carefully loaded
onto each well and resolved by SDS-PAGE using Novex NuPAGE 10% Bis-Tris Gels (Invitro-
gen). Proteins were transferred to nitrocellulose membranes (Invitrogen). Membranes were
incubated overnight at 4˚C with the following primary antibodies at the indicated dilutions—
Anti-Akt (pan) (rabbit monoclonal 1:1000, Cell Signaling Technology, clone C67E7), anti-
pAKT (Ser473, rabbit polyclonal 1:1000, Cell Signaling Technology), anti-Mtp (Microsomal
triglyceride transfer protein large subunit) (rabbit polyclonal 1:1000, Aviva Systems Biology),
anti-lipophorin (small subunit, rabbit polyclonal 1:20000) [45], anti-tubulin (mouse monoclo-
nal 1:5000, Sigma), anti-β actin (mouse monoclonal 1:1000, GeneTex Inc.). After washing,
membranes were incubated with horseradish peroxidase-conjugated anti-mouse and anti-rab-
bit secondary antibodies (Perkin Elmer) and bands were visualized with ECLTM Western Blot-
ting Detection Reagents (Amersham).
Immunostaining
Wandering third instar larval intestines were dissected and fixed for 20 minutes with 4% form-
aldehyde dissolved in PBS at room temperature for apoLpp staining. Wandering third instar
larval hearts were dissected on sylgard dishes and fixed for 10 minutes with Bouin’s solution
(saturated picric acid:formaldehyde:acetic acid in 15:5:1 ratio) at room temperature for Mtp
staining. For apoLpp staining, wandering third instar hearts were dissected on sylguard dishes
and fixed either with 4% formaldehyde dissolved in PBS at room temperature or with Bouin’s
solution for 10 minutes at room temperature. The fixed tissues were washed for 1 hour in PBS
containing 1.0% Triton X-100 (PBT) and incubated overnight at 4˚C with the anti-lipophorin
antibody (full-length, rabbit polyclonal 1:500) [45] or with the anti-Boca antibody (guinea pig
1:500) [28]. The anti-lipophorin antibodies (full-length and small subunit) as well as anti-Boca
antibody were generous gifts from Dr. Joaquim Culi, CSIC-UPO. The tissues were washed
three times for a total of 1 hour in PBT and incubated with alexa-fluor-conjugated secondary
antibodies (donkey anti-rabbit, 1;150, Jackson Immunoresearch) for 2 hours at room tempera-
ture. After washing as before, tissues were mounted in vectashield media and viewed under a
laser confocal microscope (Olympus FV1000).
RT-PCR
For whole fly samples, total RNA was extracted with Trizol reagent (Ambion). cDNA was syn-
thesized from total RNA (1 μg each) with oligo(dT) and superscript III reverse transcriptase
(Invitrogen). Subsequently, DNA was amplified using PCR master mix (Invitrogen) and the
following oligonucleotides and PCR conditions: 2 min at 95˚C, (30 sec at 95˚C, 30 sec at 55˚C,
and 30 sec at 72˚C) × 30, and 10 min at 72˚C. Actin-5C was used as an internal control. Prim-
ers used were as follows:
Actin-5C F: 5’-GGCGTAATGG TAGGAATGGG ACAAA-3’
R: 5’-GTGCTTTCT CTCTACGCCT CCGG-3’
Mtp F: 5’-TTGCTCGCTTGTGGTTTCCG-3’
R: 5’-CCTGTAAGGCAGCCACCGATAAA -3’
Real-time quantitative PCR (qPCR) analysis
For RNA extraction, 60 hearts from wandering third instar larvae or fat bodies from 20 wan-
dering third instar larvae were dissected and collected in Trizol reagent (Ambion). cDNA
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using oligo(dT) were synthesized from total RNA (400 ng each) with superscript III reverse
transcriptase (Invitrogen). qPCR amplification reactions were performed in triplicate, by mix-
ing 1 μl of RT product with 10 μl of SYBR qPCR Mastermix (Qiagen) containing the appropri-
ate PCR primers. Thermal cycling and florescence monitoring were performed in a CFX96
(Bio-rad) using the following PCR conditions: 6 min at 95˚C, 30 sec at 95˚C, 30 sec at 60˚C,
and 30 sec at 72˚C) × 35, 15 sec at 95˚C, 31 sec at 65˚C and 0.5 sec at 65˚C. Values were nor-
malized with gapdh. Primers used were as follows:
Gapdh F: 5’- GCGTCACCTGAAGATCCCAT -3’
R: 5’- GAAGTGGTTCGCCTGGAAGA -3’
Mtp F: 5’- ACGGAAATCCAGCAGAACACT -3’
R: 5’- ATACGTAAAGCCAACGGCCA -3’
apoLpp F: 5’- AATTCGCGGATGGTCTGTGT -3’
R: 5’- GCCCCTTAGGGATAGCCTTT -3’
Semi-intact drosophila heart preparation and heartbeat analysis
Cardiac contractility measurements were performed as described previously [46] on semi-
quantitative preparations of larval hearts. Briefly, wandering third instar larvae or newly-
eclosed adult females of different genotypes (about 20 larvae per genotype) were pinned down
in the anterior and posterior regions on a sylgard dissecting dish and carefully dissected to
reveal the beating hearts in an artificial hemolymph buffer [47]. High-speed 30-s movies were
recorded at a rate of>150 frames per second using a Hamamatsu CCD camera on a Nikon 80i
upright microscope with a 10x dipping immersion lens. The images were processed using Sim-
ple PCI imaging software (Compix Inc.). M-modes and quantitative data were generated using
a MatLab-based image analysis program [46].
Statistical analysis
All data are presented as the mean ± SEM of the indicated number of replicates. Data were
analyzed using the two-tailed Student’s t-test and p< 0.05 was considered statistically
significant.
Supporting Information
S1 Fig. Generation of a high-fat diet-induced model of obesity in Drosophila. (A) Experi-
mental workflow for generating obese control w1118 flies and for screening flies from each of
the 102 lines from the 2L Deficiency kit (DK2L).
(B, B0) Nutritional composition of NFD (B) and HFD (B0). These diets were of the same (NFD)
or similar (HFD) compositions to diets used in similar Drosophila studies [48]. Yellow high-
lights the % contribution of total kcal by fat.
(C) Whole-body TG levels in newly eclosed control w1118 flies (1:1 ratio of males:females) on
NFD or HFD. TG levels were normalized to total protein. Results are the mean ± SEM of the
indicated number of flies (N) analyzed over at least 4 independent experiments. P-values are
from Student’s t-test.
(D) Representative confocal images of Nile Red-stained lipid droplets in the fat body of control
w1118 third instar larvae on NFD or HFD. Arrows indicate lipid droplets and white polygons
indicate single fat cells or adipocytes.
(TIF)
S2 Fig. Mtp and apoLpp protein content is reduced in the fat body using Mtp RNAi and
different fat body-specific Gal4 drivers. (A, B) Western blot analysis of Mtp in the fat body of
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third instar larvae with Gal4 driver only. R4-Gal4 (A) or ppl-Gal4 (B) and larvae with fat body-
specific knockdown of mtp using R4-Gal4 (A) or ppl-Gal4 (B) on NFD. α-Tubulin was used as
loading control. About thirty μg of protein was loaded per lane.
(C) Representative confocal images of apoLpp staining in the hearts of control third instar lar-
vae (Hand-Gal4, left) and third instar larvae with heart-specific knockdown of apoLpp using
Hand-Gal4 (right) on HFD. Scale bars represent 20 μm. Arrows indicate the apoLpp puncta.
(TIF)
S3 Fig. Systemic lipid levels under normal food diet and high fat diet conditions in wander-
ing third instar larvae with inhibition of Mtp or apoLpp in the fat body or cardiomyocytes.
(A) Whole-body TG levels of wandering third instar larvae with Gal4 drivers only (controls)
or with fat body-specific knockdown of mtp using ppl-Gal4 on NFD (blue) or HFD (red). P-
values are from Student’s t-test and are between Gal4 control and Gal4-mediated RNAi lines
within NFD or HFD.
(B, C) Whole-body TG levels of wandering third instar larvae with Gal4 drivers only (controls)
or with cardiomyocyte-specific knockdown of mtp using Hand-Gal4 (B), or TinC-Gal4 (C) on
NFD (blue) or HFD (red). P-values are from Student’s t-test and are between Gal4 control and
Gal4-mediated RNAi lines within NFD or HFD. In all cases, TG levels (μg/μl) were normalized
to total protein (μg/μl). Results are expressed as the fold change in whole larval normalized TG
compared with that of the control larvae (set to 1.0 for NFD or HFD). Results are the
mean ± SEM of the indicated number of larvae (N) analyzed over at least 5 independent exper-
iments.
(TIF)
S4 Fig. Mtp knockdown in the pericardial cell, neuronal cell or enterocyte does not affect
systemic lipid metabolism on normal food diet and high fat diet. (A-C) Whole-body TG
levels of newly-eclosed flies with Gal4 drivers only (controls) or with tissue-specific knock-
down of mtp using pericardial cell-specific driver Sns-Gal4 (A), neuronal-specific driver ElaV-
Gal4 (B), or intestinal-specific driver cad-Gal4 (C) on NFD (blue) or HFD (red). In all cases,
TG levels (μg/μl) were normalized to total protein (μg/μl). Results are expressed as the fold
change in whole fly normalized TG compared with that of the control flies on NFD (set to 1.0).
Results are the mean ± SEM of the indicated number of flies (N) analyzed over at least 5 inde-
pendent experiments. P-values are from Student’s t-test and are between Gal4 control and
Gal4-mediated RNAi lines within NFD or HFD.
(TIF)
S5 Fig. Larval heart function is not affected by high fat diet intake. (A, A’) Representative
confocal images of Nile Red-stained lipid droplets in the hearts of control (w1118) third instar
larvae on NFD and HFD. Arrows indicate lipid droplets.
(B) Representative M-mode traces (5 s) showing movement of heart tube walls (Y-axis) versus
time (X-axis) for hearts of control (w1118) third instar larvae on NFD and HFD.
(C) Heart periods of control (w1118) third instar larvae on NFD and HFD. Results are the
mean ± SEM of the indicated number of larvae (N).
(D) Arrhythmia index (AI) of control (w1118) third instar larvae on NFD and HFD. Results are
the mean ± SEM of the indicated number of larvae (N).
(E) Cardiac contractility changes (measured as % fractional shortening) of control (w1118)
third instar larvae on NFD and HFD. Results are the mean ± SEM of the indicated number of
larvae (N).
(F) Diastolic diameter (diameter during relaxation) of the heart tubes in control (w1118) third
instar larvae on NFD and HFD. Results are the mean ± SEM of the indicated number of larvae
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(N).
(G) Systolic diameter (diameter during contraction) of the heart tubes in control (w1118) third
instar larvae on NFD and HFD. Results are the mean ± SEM of the indicated number of larvae
(N). In all cases, P-values are from Student’s t-test and are between control w1118 lines on NFD
and HFD.
(TIF)
S6 Fig. Adult heart function is not affected by Mtp inhibition in the heart on normal food
diet or high fat diet. (A) Heart periods of newly-eclosed female flies with Gal4 drivers only
(Hand-Gal4) or with cardiomyocyte-specific knockdown of mtp using Hand-Gal4 on NFD
and HFD.
(B) Arrhythmia index (AI) of newly-eclosed female flies with Gal4 drivers only (Hand-Gal4)
or with cardiomyocyte-specific knockdown of mtp using Hand-Gal4 on NFD and HFD.
(C) Diastolic diameter (diameter during relaxation) of the heart tubes in newly-eclosed female
flies with Gal4 drivers only (Hand-Gal4) or with cardiomyocyte-specific knockdown of mtp
using Hand-Gal4 on NFD and HFD.
(D) Systolic diameter (diameter during contraction) of the heart tubes in newly-eclosed female
flies with Gal4 drivers only (Hand-Gal4) or with cardiomyocyte-specific knockdown of mtp
using Hand-Gal4 on NFD and HFD.
(E) Cardiac contractility changes (measured as % fractional shortening) of newly-eclosed
female flies with Gal4 drivers only (Hand-Gal4) or with cardiomyocyte-specific knockdown of
mtp using Hand-Gal4 on NFD and HFD. In all cases, results are the mean ± SEM of the indi-
cated number of flies (N). P-values are from Student’s t-test and are between Gal4 control and
Gal4-mediated RNAi lines within NFD or HFD.
(TIF)
S7 Fig. Inhibition of Mtp only in cardiomyocytes reduces the levels of intestinal Lpp on
high fat diet. (A-C) Representative confocal images of apoLpp staining in the intestines of
control third instar larvae (Hand-Gal4, left), in the intestines of third instar larvae with heart-
specific knockdown of mtp using Hand-Gal4 (middle), and in the intestines of third instar lar-
vae with heart-specific knockdown of apoLpp using Hand-Gal4 (right) on HFD. In all cases,
arrows indicate the apoLpp puncta which reflect the presence of Lpp. Scale bars represent
40 μm.
(TIF)
S8 Fig. High fat diet alters relative Mtp and apoLpp protein levels in the fat body. (A)
Western blot analysis of Mtp protein level in the fat body of control (w1118) third instar larvae
on NFD and HFD. α-Tubulin was used as loading control. Forty μg of protein were loaded per
lane.
(B) Western blot analysis of apoLpp protein levels in the fat body of control (w1118) third instar
larvae on NFD and HFD. α-Tubulin was used as loading control. Twenty μg of protein were
loaded per lane.
(TIF)
S9 Fig. Inhibition of Mtp or apoLpp in the fat body or cardiomyocytes differentially alters
circulating Lpp abundance under NFD and HFD conditions. (A, B) Western blot analysis of
apoLpp in the hemolymph extracted from third instar larvae with Gal4 driver only (ppl-Gal4)
or from third instar larvae with fat body-specific knockdown of mtp using ppl-Gal4 on NFD
(A) and HFD (B). 1 μl of extracted hemolymph was diluted 10-fold and 5 μl of the diluted sam-
ple used for Bradford protein assay. Based on the protein assay, twenty-three μg of protein
were loaded per lane.
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(C, D) Western blot analysis of apoLpp in the hemolymph extracted from third instar larvae
with Gal4 driver only (Hand-Gal4) or from third instar larvae with fat body-specific knock-
down of mtp using Hand-Gal4 on NFD (C) and HFD (D). 1 μl of extracted hemolymph was
diluted 10-fold and 5 μl of the diluted sample used for Bradford protein assay. Based on the
protein assay, twenty-three μg of protein were loaded per lane.
(TIF)
S1 Table. Effects of mtp or apoLppi knockdown mediated by all drivers used in this study
on developmental timing and viability.
(TIF)
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